Investigating how a specific protein helps control inflammation and fight viruses
Anti-inflammatory functions for non-transcriptional IRF3
This study is looking at a protein called IRF3 to see how it helps our immune system fight off viruses and control inflammation, which could lead to better ways to treat infections and inflammatory diseases for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-11031926 on NIH RePORTER |
What this research studies
This research focuses on the role of a protein called IRF3 in the immune response, particularly its ability to fight viral infections and regulate inflammation. The study explores both the traditional and non-traditional functions of IRF3, including its ability to induce cell death in virus-infected cells and inhibit inflammatory responses. By using genetically modified mice, researchers aim to understand how IRF3 can protect against infections and inflammatory diseases, which could lead to new treatment strategies. Patients may benefit from insights gained about managing inflammatory conditions and viral infections.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with viral infections or inflammatory conditions, particularly those related to liver diseases.
Not a fit: Patients who do not have viral infections or inflammatory diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for patients suffering from viral infections and inflammatory diseases.
How similar studies have performed: Previous research has shown promising results in understanding the immune functions of IRF3, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Chattopadhyay, Saurabh — University of Kentucky
- Study coordinator: Chattopadhyay, Saurabh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.